Vertical dynamic visual acuity is significantly lower than horizontal dynamic visual acuity.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 Nov 2023
Historique:
received: 18 05 2023
accepted: 24 11 2023
medline: 30 11 2023
pubmed: 29 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

Dynamic visual acuity (DVA) is crucial for the perception of moving objects. While traditional DVA assessment tools predominantly focus on horizontal movements, the evaluation of vertical DVA remains unstandardized. Consequently, the disparities between vertical and horizontal DVAs are yet to be thoroughly investigated. Therefore, we designed a system capable of conducting multidirectional DVA tests and eye movement measurements. During the experiments, the participants identified the gap direction of the Landolt-C ring moving either horizontally or vertically. The speed of movement decelerated from its maximum as a high-speed infrared camera captured the pupil movements of the left eye at 500 fps. We conducted tests on 15 healthy university students (aged [Formula: see text] years) and measured vertical and horizontal DVAs five times each. DVA was deduced from the Landolt-C ring speed with accurate gap direction responses, and eye movement was assessed based on the total gaze movement distance. The results revealed superior DVA and eye movement in the horizontal direction compared with the vertical direction ([Formula: see text]). This highlights the anisotropic characteristics of DVA and eye movement. The proposed system has the potential for multidirectional dynamic vision evaluation and training in clinical scenarios.

Identifiants

pubmed: 38017190
doi: 10.1038/s41598-023-48292-1
pii: 10.1038/s41598-023-48292-1
pmc: PMC10684582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20999

Informations de copyright

© 2023. The Author(s).

Références

Otol Neurotol. 2002 May;23(3):372-7
pubmed: 11981398
Front Neurol. 2019 Apr 16;10:365
pubmed: 31105632
Biol Cybern. 1989;60(6):411-20
pubmed: 2719979
Int J Ophthalmol. 2017 Sep 18;10(9):1460-1464
pubmed: 28944208
J Mot Behav. 1974 Jun;6(2):87-94
pubmed: 23952697
Atten Percept Psychophys. 2015 Aug;77(6):2061-73
pubmed: 25893472
J Assoc Res Otolaryngol. 2006 Dec;7(4):329-38
pubmed: 16810569
Optom Vis Sci. 1995 Mar;72(3):186-91
pubmed: 7609941
J Am Optom Assoc. 1988 Dec;59(12):946-50
pubmed: 3209790
Ann N Y Acad Sci. 2001 Oct;942:428-45
pubmed: 11710482
Eye Contact Lens. 2011 May;37(3):127-30
pubmed: 21451416
IEEE Trans Biomed Eng. 1982 Oct;29(10):686-93
pubmed: 6897393
Clin Ophthalmol. 2013;7:627-32
pubmed: 23569356
Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):819-24
pubmed: 12925338
Invest Ophthalmol Vis Sci. 1993 May;34(6):1894-906
pubmed: 8491542
J Appl Psychol. 1966 Dec;50(6):460-6
pubmed: 5978038
J Am Optom Assoc. 1982 Aug;53(8):627-33
pubmed: 7130603
Res Q Exerc Sport. 2011 Dec;82(4):644-51
pubmed: 22276406
Percept Mot Skills. 1993 Dec;77(3 Pt 1):835-9
pubmed: 8284163
Optom Clin. 1993;3(1):145-69
pubmed: 8324322
Nat Neurosci. 2018 Sep;21(9):1281-1289
pubmed: 30127430
PLoS One. 2017 Feb 10;12(2):e0172061
pubmed: 28187157
Front Neurol. 2019 Apr 09;10:321
pubmed: 31024422
Am J Otol. 1998 Nov;19(6):790-6
pubmed: 9831156
Clin Exp Optom. 2019 Jan;102(1):51-56
pubmed: 30054950
Vision Res. 1972 Feb;12(2):305-21
pubmed: 5033692
Eur Arch Otorhinolaryngol. 2020 Jan;277(1):103-113
pubmed: 31637477
PLoS One. 2012;7(2):e31530
pubmed: 22384033
J Phys Ther Sci. 2019 Jan;31(1):53-56
pubmed: 30774205

Auteurs

Aoi Tachihara (A)

Electrical, Systems, and Control Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-Hiroshima, Hiroshima, 739-8527, Japan.

Zu Soh (Z)

Electrical, Systems, and Control Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-Hiroshima, Hiroshima, 739-8527, Japan. sozu@bsys.hiroshima-u.ac.jp.

Tomohiko Mizuguchi (T)

New Business Producing Division, Maxell Ltd., Yokohama, 240-0005, Japan.

Akihiko Kandori (A)

Center for Exploratory Research, Research and Development Group, Hitachi. Ltd., Tokyo, 185-8601, Japan.

Seiji Hama (S)

Department of Rehabilitation, Hibino Hospital, Hiroshima, 731-3164, Japan.
Department of Neurosurgery, Center for Brain, Mind and KANSEI Sciences Research, Hiroshima University, Hiroshima, 734-8553, Japan.

Toshio Tsuji (T)

Electrical, Systems, and Control Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-Hiroshima, Hiroshima, 739-8527, Japan. tsuji-c@bsys.hiroshima-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH